Compare MPLT & TDAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPLT | TDAY |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | 133 | 7500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | MPLT | TDAY |
|---|---|---|
| Price | $37.09 | $8.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $32.67 | $9.00 |
| AVG Volume (30 Days) | 437.1K | ★ 1.6M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.24 | $4.54 |
| 52 Week High | $37.61 | $8.90 |
| Indicator | MPLT | TDAY |
|---|---|---|
| Relative Strength Index (RSI) | 69.84 | 68.49 |
| Support Level | $26.20 | $6.67 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.49 | 0.28 |
| MACD | 0.84 | 0.09 |
| Stochastic Oscillator | 95.22 | 95.31 |
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
USA Today Co Inc is a diversified media company with national and local reach, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.